Search
for
Sort by
Research 91–120 of 1000+
- Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- A case of myasthenia gravis following alopecia areata
- Teriflunomida and hair disorders
- Trichoscopy of dissecting cellulitis of the scalp: Exclamation mark hairs and white dots as markers of disease chronicity
- Hypertrichosis as a side effect of inhaled steroids in children
- Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin
- Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries
- Drug-induced alopecia areata: A systematic review
- Disproportionality analysis comparing safety profiles of sonidegib and vismodegib based on the FAERS database
- Scarring Alopecias in a Pediatric Trichology Clinic at a Tertiary Care Center
- A prospective cross-sectional study on post COVID-19 hair loss at a tertiary care hospital
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions
- Hidradenitis suppurativa and associated factors: Still unsolved problems
- Characteristics of hair loss after COVID‐19: A systematic scoping review
- Shortcutting the diagnostic odyssey: the multidisciplinary Program for Undiagnosed Rare Diseases in adults (UD-PrOZA)
- Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
- Drug induced hair loss.
- COVID-19 patients at referral to hospital during the first peak of disease: Common clinical findings including myalgia and fatigue
- Natural course of epidermolysis bullosa simplex with mottled pigmentation in a Japanese family with the p.P25L mutation in <i> KRT 5 </i>
- Retrospective Study about the Effectiveness of Korean Medical Treatment on 222 Patients with Alopecia Areata
- Diphenylcyclopropenone Treatment Outcomes for Alopecia Areata
- Telogen effluvium as the first symptom of Crohn's disease in a child.
- Drug points: Remission of alopecia universalis during sulphasalazine treatment for rheumatoid arthritis
- The Predictive Value of Midscalp Hair Density and Terminal Hair Percentage in the Severity Evaluation of FPHL Assessed by Trichoscan in a Sample of Chinese Population
- Correlation of trichoscopic findings with clinico-epidemiological factors in male pattern&nbsp;<span style="font-size: 1rem;">hairloss: A cross-sectional study from a tertiary care center in Chengalpattu</span>
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- Attention to Innate Circadian Rhythm and the Impact of Its Disruption on Diabetes
- 32731 Alopecia in COVID-19 patients: Systematic review and meta-analysis
- Massive squamous cell carcinoma arising from hidradenitis suppurativa with marked hypercalcemia and neutrophilia